Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech Republic from 2013–2016: data from the national registry ReMuS

Conclusion: Data from the ReMuS registry highlights improvements made in the management of MS in the Czech Republic. However, a relatively low percentage of patients started treatment using second-line drugs, in contrast to trends in other countries.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research